Source:http://linkedlifedata.com/resource/pubmed/id/12636161
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2003-3-14
|
pubmed:abstractText |
The aim of this work was to investigate the cellular binding and processing of polyethylene glycol-stabilized epidermal growth factor (EGF) liposomes. The liposomes were actively loaded with water-soluble boronated acridine (WSA), primarily developed for boron neutron capture therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0724-8741
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
229-36
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12636161-Acridines,
pubmed-meshheading:12636161-Animals,
pubmed-meshheading:12636161-Boron Compounds,
pubmed-meshheading:12636161-Dose-Response Relationship, Drug,
pubmed-meshheading:12636161-Drug Delivery Systems,
pubmed-meshheading:12636161-Epidermal Growth Factor,
pubmed-meshheading:12636161-Humans,
pubmed-meshheading:12636161-Liposomes,
pubmed-meshheading:12636161-Tumor Cells, Cultured
|
pubmed:year |
2003
|
pubmed:articleTitle |
Tumor-cell targeted epiderimal growth factor liposomes loaded with boronated acridine: uptake and processing.
|
pubmed:affiliation |
Division of Biomedical Radiation Sciences, Department of Oncology, Radiology and Clinical Immunology, Rudbeck Laboratory, Uppsala University, S-751 85 Uppsala, Sweden. Erika.Bohl@bms.uu.se
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|